Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
2020 6
2021 1
2022 2
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis.
D'Alessandro M, Bergantini L, Cameli P, Landi C, Lanzarone N, Perrone A, Alonzi V, Perillo F, Bianchi F, Metella Refini R, Pieroni M, Sestini P, Bargagli E. D'Alessandro M, et al. Among authors: alonzi v. Panminerva Med. 2022 Dec;64(4):548-554. doi: 10.23736/S0031-0808.20.04056-2. Epub 2020 Dec 4. Panminerva Med. 2022. PMID: 33274906 Review.
COVID-19 severity appears to be reduced in spring/summer.
Sposato B, Serafini A, Simoncini E, Croci L, Guidoni C, Scalese M, Baratta P, Cresti A, Lacerenza LG, Lena F, Nencioni C, Spargi G, Perrella A; Grosseto COVID Group. Sposato B, et al. Epidemiol Prev. 2023 Jan-Apr;47(1-2):34-46. doi: 10.19191/EP23.1.A503.016. Epidemiol Prev. 2023. PMID: 36971236 English.
Immunologic responses to antifibrotic treatment in IPF patients.
d'Alessandro M, Bergantini L, Cameli P, Fanetti M, Alderighi L, Armati M, Refini RM, Alonzi V, Sestini P, Bargagli E. d'Alessandro M, et al. Among authors: alonzi v. Int Immunopharmacol. 2021 Jun;95:107525. doi: 10.1016/j.intimp.2021.107525. Epub 2021 Mar 11. Int Immunopharmacol. 2021. PMID: 33714885
Serum KL-6 levels in pulmonary Langerhans' cell histiocytosis.
d'Alessandro M, Bergantini L, Cameli P, Lanzarone N, Antonietta Mazzei M, Alonzi V, Sestini P, Bargagli E. d'Alessandro M, et al. Among authors: alonzi v. Eur J Clin Invest. 2020 Apr 20:e13242. doi: 10.1111/eci.13242. Online ahead of print. Eur J Clin Invest. 2020. PMID: 32307698
Serum KL-6 concentrations as a novel biomarker of severe COVID-19.
d'Alessandro M, Cameli P, Refini RM, Bergantini L, Alonzi V, Lanzarone N, Bennett D, Rana GD, Montagnani F, Scolletta S, Franchi F, Frediani B, Valente S, Mazzei MA, Bonella F, Bargagli E. d'Alessandro M, et al. Among authors: alonzi v. J Med Virol. 2020 Oct;92(10):2216-2220. doi: 10.1002/jmv.26087. Epub 2020 Jun 9. J Med Virol. 2020. PMID: 32470148 Free PMC article.
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features.
Lanzarone N, Gentili F, Alonzi V, Bergantini L, d'Alessandro M, Rottoli P, Refini RM, Pieroni M, Vietri L, Bianchi F, Mazzei MA, Volterrani L, Perrone A, Cameli P, Bargagli E, Sestini P. Lanzarone N, et al. Among authors: alonzi v. Intern Emerg Med. 2020 Oct;15(7):1247-1254. doi: 10.1007/s11739-020-02281-8. Epub 2020 Feb 20. Intern Emerg Med. 2020. PMID: 32078140